On January 21st, the Centers for Disease Control and Prevention (CDC) issued a press release outlining the first case of a novel coronavirus from a patient traveling from the Wuhan province of China.
CDC Announces that Novel Coronavirus Hits the US
Why We’re Facing a Potential Shortfall of New Antibiotics, and What We Can Do About It
Given the dependence of modern medicine on antimicrobial drugs, and the inevitability of evolution, why is bringing a new antibiotic to market so difficult, and why are so many companies leaving the industry or going bankrupt?
We Can’t Rely on Development of New Drugs Alone to Combat Antimicrobial Resistance
Antimicrobial resistance (AMR) presents a global health crisis, as every day we encounter more infections that cannot be cured with existing antimicrobials. At the same time, the majority of major drug companies have been scaling back or cutting antibiotic research due to development challenges
Policies & Guidelines That Will Help Drive Antimicrobial Stewardship in 2020
Significant action from national and international leadership is needed to encourage and require antimicrobial stewardship programs in healthcare organizations.
Keys to Success for Hospital Antimicrobial Stewardship Programs
AMR has been identified as a major threat by the...
Antimicrobial Resistance: Pay Now or Pay Much More Later, Warns New Report
Lack of resources for action against antimicrobial resistance could have...